Greencare Capital will focus on investing in companies which produce medicinal cannabis, hemp or items containing CBD, one of the non-psychoactive ingredients in cannabis. The shares floated at a …
More MARKET REPORT: Pharma giant Astrazeneca wins go-ahead for cancer drug Videos